{"id":"W2612252842","doi":"10.1097/01.cot.0000520166.95325.d1","title":"First Drug Approved for Merkel Cell Carcinoma Achieves Strong Response","year":2017,"lang":"en","type":"article","venue":"Oncology Times","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Merkel cell carcinoma; Avelumab; Medicine; Merkel cell polyomavirus; Merkel cell; Cancer; Dermatology; Chemotherapy; Melanoma; Oncology; Carcinoma; Internal medicine; Immunotherapy; Cancer research; Nivolumab","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002772438,0.000158537,0.0003471595,0.00006648705,0.0005878906,0.00002778479,0.0002157462,0.000204456,0.0002067603],"category_scores_gemma":[0.0003329926,0.0001222275,0.0001700055,0.00002062599,0.0002731739,0.00008059823,0.00008574923,0.000169136,0.0001329832],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008494467,"about_ca_system_score_gemma":0.0004041509,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001023877,"about_ca_topic_score_gemma":0.00003830288,"domain_scores_codex":[0.9990397,0.0000663827,0.0001906111,0.0002787523,0.00009446139,0.0003301046],"domain_scores_gemma":[0.9986293,0.0003659249,0.0001785303,0.0005582026,0.00005549141,0.0002126038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05292521,0.004083788,0.09894329,0.0006202968,0.0006605387,0.0009133436,0.00219256,0.00003333241,0.03324361,0.002073155,0.787344,0.01696686],"study_design_scores_gemma":[0.01116453,0.002101765,0.3459919,0.00007530763,0.0008925287,0.00005306155,0.0005268329,0.001675187,0.01029858,0.0003002817,0.6265621,0.0003578976],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9099192,0.001862056,0.00003718972,0.01187421,0.0004067473,0.0006425133,0.0000729383,0.00006953125,0.0751156],"genre_scores_gemma":[0.887979,0.00003368508,0.001056153,0.0002559227,0.0001987498,0.00007898488,0.00002003034,0.00002637775,0.110351],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2470486,"threshold_uncertainty_score":0.4984295,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02154805255533929,"score_gpt":0.3117952358933817,"score_spread":0.2902471833380423,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}